Videos / Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis
In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).
This Product Explainer is supported by CSL Seqirus

Abnormal Liver Function Test

Recurrent Nasal Polyps Management – When to Refer

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

Vitiligo – Early Detection and Early Treatment

expert
Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon, Macquarie University, St Vincent's Hospitals, Sydney; Program Head, Rhinology & Skull Base Surgery, Applied Medical Research Center, UNSW; Professor, UNSW, Macquarie University